Infectious Diseases

Infectious Diseases Revenue Growth Economic Policy Trade Policies Stock Performance Supply Chain Management Tariffs Laboratory Techniques Infectious Diseases Pharmaceuticals

6 ARTICLES

last mo.

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

The company surpassed analyst expectations, reaffirmed 2025 guidance, and outlined strategies to mitigate tariff impacts while navigating mixed portfolio performance.

3 ARTICLES

2mo ago

Antibiotic-Resistant Gonorrhoea Cases Continue to Rise in England, Health Officials Warn

4 ARTICLES

2mo ago

Researchers Discover New Antibiotic Lariocidin with Novel Resistance-Fighting Mechanism